Skip to main content
Clinical Trials/ISRCTN43397016
ISRCTN43397016CompletedPhase 3

Alternative Treatments of Adult Female Urinary Tract Infection: a double-blind, placebo-controlled, factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen

niversity of Southampton0 sites376 target enrollmentStarted: February 11, 2015Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
376

Study Overview

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • 1. Adult women (18-70) presenting to primary care with suspected lower urinary tract infection i.e. with at least one of dysuria, urgency or frequency
  • 2. Patient able to provide informed written consent
  • 3. Women willing to accept a delayed prescription for antibiotics

Exclusion Criteria

  • Current exclusion criteria as of 13/09/2016:
  • 1. Known or suspected pregnancy or breast feeding. In women of child bearing age a urine pregnancy test will usually be performed unless not indicated (for instance prior hysterectomy)
  • 2. Known immunodeficiency state, long term corticosteroids therapy or chemotherapy
  • 3. Diabetes
  • 4. Has any of the following known contraindications or cautions to Ibuprofen and any as listed in the current SmPC:
  • 4.1. Asthmatics sensitive to NSAIDS/Ibuprofen or Aspirin
  • 4.2. Severe heart failure and uncontrolled hypertension
  • 4.3. Active gastrointestinal ulceration or bleeding
  • 4.4. Crohn’s disease or ulcerative colitis
  • 4.5. Documented poor renal function
  • 4.6. Chronic Kidney disease (Grade 3-5)
  • 5. Currently or within 7 days taken antibiotics
  • 6. Using a NSAID or Uva Ursi preparation and unwilling to discontinue for the study period
  • 7. Suspected upper urinary tract infection (back pain, high fever>38C, systemic illness)
  • 8. Women whom immediate antibiotics are otherwise indicated frequent recurrent infection: >3 UTI episodes in past 12 months
  • 9. Defect of the blood clotting system
  • 10. Bladder surgery including cystoscopy in the last four weeks
  • 11. Currently taking Warfarin
  • 12. Recruited to another interventional trial in previous 6 weeks
  • Previous exclusion criteria:
  • 1. Known or suspected pregnancy or breast feeding. In women of child bearing age a urine pregnancy test will usually be performed unless not indicated (for instance prior hysterectomy)
  • 2. Known immunodeficiency state, long term corticosteroids therapy or chemotherapy
  • 3. Diabetes
  • 4. Has any of the following known contraindications or cautions to Ibuprofen and any as listed in the current SmPC:
  • 4.1. Asthmatics sensitive to NSAIDS/Ibuprofen or Aspirin
  • 4.2. Severe heart failure and uncontrolled hypertension
  • 4.3. Active gastrointestinal ulceration or bleeding
  • 4.4. Crohn’s disease or ulcerative colitis
  • 4.5. Documented poor renal function
  • 4.6. Chronic Kidney disease
  • 5. Currently or within 7 days taken antibiotics
  • 6. Using a NSAID or Uva Ursi preparation and unwilling to discontinue for the study period
  • 7. Suspected upper urinary tract infection (back pain, high fever>38C, systemic illness)
  • 8. Women whom immediate antibiotics are otherwise indicated frequent recurrent infection: >3 UTI episodes in past 12 months
  • 9. Defect of the blood clotting system
  • 10. Bladder surgery including cystoscopy in the last four weeks.
  • 11. Currently taking Warfarin
  • 12. Recruited to another trial in previous 4 weeks.

Investigators

Sponsor
niversity of Southampton

Similar Trials